Jesco Pfitzenmaier,Sascha Pahernik,Stephan Buse,Axel Haferkamp,Nenad Djakovic,Markus Hohenfellner.Survival in prostate cancer patients ≥70 years after radical prostatectomy and comparison to younger patients[J]. World Journal of Urology .2009(5)...
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 Purpose To determine whether there is a benefit to adjuvant radiation therapy after breast-conserving surgery and tamoxifen in women age 70 years with...
After an initial period of tumor regression, prostate cancers become unresponsive to these therapies and eventually progress to the “castrate-resistant” state. Currently, there is no curative treatment available for castrate-resistant prostate cancer, and chemotherapy has limited benefits in improving ...
A 74-year-old man presented with rapid rising prostate-specific antigen (PSA) 2 years after treatment of prostate cancer with prostatectomy and salvage rad... E Sorra,MU Aziz,F Peng - 《Nuclear Medicine & Molecular Imaging》 被引量: 0发表: 2019年 ...
1. Radiotherapy for early-stage prostate cancer in men under 70 years of age [J] . Bellavita Rita, Scricciolo Melissa, Bini Vittorio, Tumori. . 2016,第2期 机译:70岁以下男性的早期前列腺癌放疗 2. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy...
[62], suggesting immune escape as a progression pathway in prostate cancer. However, after a promising start and demonstration of improvements in OS in 2010 with the injection of activated autologous peripheral-blood mononuclear cells [63], the outcomes provided by immune check-point inhibitors ...
The characteristics shown in Table S1 include the clinical characteristics and tumor features of patients with prostate cancer. In this population, 3.26% of patients were under the age of 50, 96.74% of patients were 50 years of age or older (Table 1). Most of them were white, married, ...
Kanio S; Ohyama C; Okada y;.Clinical features of prostate cancer patients younger than 50 years, report of seven cases.Int J Urol.2002... S Kanto,C Ohyama,Y Okada,... - 《International Journal of Urology》 被引量: 43发表: 2010年 Prostate Cancer Diagnosis and Treatment After the Introd...
[with advanced prostate cancer] live longer, other than testosterone suppression,” Nelson said. “That was the standard of care — and still is — for more than 70 years. But other than that, there were no life-prolonging treatments [for metastatic cancer]. So it was a pretty desperate ...
prostate cancer has spread beyond the prostate and nearby structures, survival rates fall. "Distant" prostate cancer has moved into farther-away areas of the body, such as the bones, liver, or lungs. Among those with distant prostate cancer, about one-third will survive for 5 years after ...